Despite a shaky start, the US coronavirus testing programme was able to provide tests to those in need by the end of last year.
When vaccines arrived, though, the focus shifted. Because so many people who had been immunised didn’t think they needed to be tested, the market for these tests dropped precipitously. Abbott Laboratories, a prominent test maker, was forced to destroy millions of tests after closing or converting testing sites into vaccination centres.
The new Omicron variety has sparked a resurgence in demand for testing, which is outpacing supply.
This episode of “The Daily” examines the current state of testing in the United States and the options available to the Biden administration.